The Recall Desk

Hazard

Penicillin Cross Contamination recalls

315 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
315
Critical
0
Severe
284
Most recent
2016-07-27

Of the 315 penicillin cross contamination recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 284 (90%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all penicillin cross contamination recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

176–200 of 315

  • SevereFDA (Drugs)·D-601-2015·2015-04-29

    Attix Pharmaceuticals Recalls Croscarmellose Sodium Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Croscarmellose Sodium pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Croscarmellose Sodium pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-722-2015·2015-04-29

    Attix Pharmaceuticals Recalls Hydroxypropyl Beta Cyclodextrin Due to Penicillin Cross-Contamination

    Attix Pharmaceuticals is recalling Hydroxypropyl Beta Cyclodextrin active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Hydroxypropyl Beta Cyclodextrin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-691-2015·2015-04-29

    Attix Pharmaceuticals Recalls Formestane API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Formestane active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Formestane active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-675-2015·2015-04-29

    Attix Pharmaceuticals Recalls Flibanserin API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Flibanserin active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Flibanserin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-544-2015·2015-04-29

    Attix Pharmaceuticals Recalls Bisacodyl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Bisacodyl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Bisacodyl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-651-2015·2015-04-29

    Attix Pharmaceuticals Recalls Esomeprazole Magnesium Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Esomeprazole Magnesium Trihydrate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Esomeprazole Magnesium Trihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-799-2015·2015-04-29

    Attix Pharmaceuticals Recalls Minocycline HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Minocycline HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Minocycline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-659-2015·2015-04-29

    Etamsylate API Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Etamsylate active pharmaceutical ingredient due to potential penicillin cross contamination during repackaging.

    Product
    Etamsylate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-621-2015·2015-04-29

    Attix Pharmaceuticals Recalls Desonide API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Desonide active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Desonide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-849-2015·2015-04-29

    Attix Pharmaceuticals Recalls Potassium Acetate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Potassium Acetate active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to a risk of penicillin cross-contamination.

    Product
    Potassium Acetate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-802-2015·2015-04-29

    Attix Pharmaceuticals Recalls Misoprostol API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Misoprostol 1% active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Misoprostol 1% active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-509-2015·2015-04-29

    Attix Pharmaceuticals Recalls Amantadine HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Amantadine HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Amantadine HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-704-2015·2015-04-29

    Attix Pharmaceuticals Recalls Heptaminol Hydrochloride Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Heptaminol Hydrochloride active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Heptaminol Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-496-2015·2015-04-29

    Attix Pharmaceuticals Recalls DMSA Ingredient Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling 2,3-Dimercaptosuccinic Acid (DMSA) active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    2,3-Dimercaptosuccinic Acid (DMSA) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-917-2015·2015-04-29

    Attix Pharmaceuticals Recalls Telaprevir API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Telaprevir active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Telaprevir active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-553-2015·2015-04-29

    Attix Pharmaceuticals Recalls Bupropion HCI Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Bupropion HCI active pharmaceutical ingredient due to potential penicillin cross-contamination from repackaging in a shared facility.

    Product
    Bupropion HCI active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-845-2015·2015-04-29

    Attix Pharmaceuticals Recalls Piroxicam Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling piroxicam active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Piroxicam active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-937-2015·2015-04-29

    Attix Pharmaceuticals Recalls Tramadol HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Tramadol HCl active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Tramadol HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-619-2015·2015-04-29

    Attix Pharmaceuticals Recalls Demeclocycline HCl Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Demeclocycline HCl active pharmaceutical ingredient due to potential penicillin cross-contamination from repackaging in a shared facility.

    Product
    Demeclocycline HCl active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-508-2015·2015-04-29

    Alpha Chymotrypsin Recalled for Potential Penicillin Cross Contamination

    Attix Pharmaceuticals is recalling Alpha Chymotrypsin active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Alpha Chymotrypsin active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-927-2015·2015-04-29

    Attix Pharmaceuticals Recalls Thiotepa Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Thiotepa active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Thiotepa active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-928-2015·2015-04-29

    Attix Pharmaceuticals Recalls Thyroid Porcine Ingredient Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Thyroid Porcine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Thyroid Porcine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-801-2015·2015-04-29

    Attix Pharmaceuticals Recalls Mirtazapine API Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Mirtazapine active pharmaceutical ingredient due to potential penicillin cross-contamination from inadequate facility separation.

    Product
    Mirtazapine active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-706-2015·2015-04-29

    Attix Pharmaceuticals Recalls Histamine Phosphate Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling Histamine Phosphate active pharmaceutical ingredient due to potential penicillin cross-contamination during repackaging.

    Product
    Histamine Phosphate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-850-2015·2015-04-29

    Attix Pharmaceuticals Recalls Potassium Chloride Due to Penicillin Cross-Contamination Risk

    Attix Pharmaceuticals is recalling all lots of Potassium Chloride active pharmaceutical ingredient distributed between January 5, 2012, and February 12, 2015, due to potential penicillin cross-contamination.

    Product
    Potassium Chloride active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
    Category
    Drug
    Distribution
    Distributed nationwide